WW-ADNI is a collaborative effort of scientists from around the world convened by the Alzheimer’s Association and is the umbrella organization for neuroimaging initiatives being carried out globally. World Wide ADNI (WW-ADNI) unites leading international investigators in a common effort to:
- Help predict and monitor the onset and progression of Alzheimer’s disease
- Establish globally recognized standards to identify and diagnose Alzheimer’s disease
- Document cognitive changes linked to physical changes
- Share data across the international research community
Each WW-ADNI site collects clinical and biomarker data from participants. Biomarker data may include imaging data (MRI, PET) or fluid biomarker data (CSF, plasma). WW-ADNI has a goal of making most of the clinical, neuropsychological, imaging, and biological data gathered available to the scientific community.
The Active WW-ADNI Sites include:
- North American ADNI (NA-ADNI)
- European ADNI (E-ADNI)
- Australian Imaging, Biomarker & Lifestyle (AIBL)
- Japan ADNI (J-ADNI)
- Korea ADNI
- Argentina ADNI
- China ADNI
- India ADNI